RM2-ANTIGENE UND VERWENDUNG DAVON
European patent · EP3013365 · In force
Register entry
- Publication number
- EP3013365
- Application number
- EP14817316
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 26, 2014
- Published
- May 4, 2016
- Granted
- Jun 5, 2019
- Protection ends at the latest
- Jun 25, 2034
- Next annual fee due
- Jun 30, 2027
- IPC classes
- A61K 39/385 (2006.01)C07K 14/33 (2006.01)
- Priority
- US 201361839648 P 26.06.2013
- PCT application
- PCT/US2014/044465 26.06.2014
- PCT publication
- WO2014/210397 31.12.2014
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.06.2026 → 30.06.2027
Published in Swissreg on 01.07.2026
- Jul 1, 2025
Next annual fee due on
- Next annual fee due on
- 30.06.2025 → 30.06.2026
Published in Swissreg on 01.07.2025
- Jul 4, 2024
Change
Published in Swissreg on 04.07.2024
- Jul 1, 2023
Change
Published in Swissreg on 01.07.2023
- Jul 6, 2022
Change
Published in Swissreg on 06.07.2022
- Feb 14, 2020
Address changed
- Representative
- TR-IP Consulting LLC, Route de Coutset 18, 1485 Nuvilly → TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly
Published in Swissreg on 14.02.2020
- Jul 20, 2019
Agent entered
- Representative
- TR-IP Consulting LLC, Route de Coutset 18, 1485 Nuvilly
Published in Swissreg on 20.07.2019
- Jun 5, 2019
Granted
Published in Swissreg on 05.06.2019
Parties
Inventor
Taipei 116, TW
New Taipei 221, TW
Tainan 701, TW
Rancho Santa Fe, California 92067, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.